m-Chlorophenylpiperazine
- Generic Name
- m-Chlorophenylpiperazine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C10H13ClN2
- CAS Number
- 6640-24-0
- Unique Ingredient Identifier
- REY0CNO998
- Background
m-Chlorophenylpiperazine has been used in trials studying the treatment of Alcoholism.
- Associated Conditions
- -
- Associated Therapies
- -
Effect of mCPP on Cognitive Control, Appetite, and Neural Responses
Not Applicable
Terminated
- Conditions
- Interventions
- First Posted Date
- 2019-05-24
- Last Posted Date
- 2020-11-06
- Lead Sponsor
- University of Birmingham
- Target Recruit Count
- 32
- Registration Number
- NCT03962829
- Locations
- 🇬🇧
University of Birmingham School of Psychology, Birmingham, Midlands, United Kingdom
Modulation of Pharmacologically Induced Alcohol Craving in Recently Detoxified Alcoholics
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-01-31
- Last Posted Date
- 2012-07-03
- Target Recruit Count
- 37
- Registration Number
- NCT00605904
- Locations
- 🇺🇸
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Alterations in Serotonergic Functions in Cocaine Addicts - 1
Phase 1
Completed
- Conditions
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000312
- Locations
- 🇺🇸
VA Medical Center, Brooklyn, New York, United States
M-CPP and Fenfluramine in Cocaine Addicts - 3
Phase 2
Completed
- Conditions
- First Posted Date
- 1999-09-21
- Last Posted Date
- 2017-01-18
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Registration Number
- NCT00000314
- Locations
- 🇺🇸
VA Medical Center, Brooklyn, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath